QTORIN
Dead / Abandoned — Abandoned — no statement of use filed (as of 23 Dec 2019)
What this means for you
This application is over — abandoned 23 Dec 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88103229
- Mark type
- Stylized text
- Filed
- 04 Sept 2018
- Published for opposition
- 26 Mar 2019
- Abandoned
- 23 Dec 2019
- Attorney of record
- Lori E. Harrison
Goods and services
- Class 005 — Pharmaceuticals: Chemical drug delivery agent in the form of a semi-solid dissolvable medical gel that facilitates the delivery of rapamycin by enabling and facilitating the placement of agents that act on mammalian targets for the delivery of rapamycin in and on the skin
- Class 039 — Transportation and storage services: Delivery of goods, namely, delivery of chemical delivery systems for a medical topical gel application
Owner
- Palvella Therapeutics, Inc., Wayne, PA, US
- Palvella Therapeutics, Inc., Wayne, PA, US
Prosecution history
- 23 Dec 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Dec 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 21 May 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Mar 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Mar 2019 — PUBLISHED FOR OPPOSITION
- 06 Mar 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Feb 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Feb 2019 — EXAMINER'S AMENDMENT ENTERED
- 08 Feb 2019 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 08 Feb 2019 — EXAMINERS AMENDMENT E-MAILED
- 08 Feb 2019 — EXAMINERS AMENDMENT -WRITTEN
- 07 Feb 2019 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 29 Jan 2019 — WITHDRAWN FROM PUB - OG REVIEW QUERY
- 14 Jan 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Jan 2019 — EXAMINER'S AMENDMENT ENTERED